Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer

被引：0
|
作者：
Matti S. Aapro
Stephen Chaplin
Paul Cornes
Sebastian Howe
Hartmut Link
Natalia Koptelova
Andrea Mehl
Mario Di Palma
Bridgette Kanz Schroader
Robert Terkola
机构：
[1] Genolier Cancer Center,Gustave Roussy
[2] Xcenda UK,undefined
[3] Comparative Outcomes Group,undefined
[4] Sandoz International GmbH,undefined
[5] Private Practice Hematology Oncology Kaiserslautern,undefined
[6] Paris-Saclay University,undefined
[7] Xcenda LLC,undefined
[8] a Cencora company,undefined
[9] University Medical Center,undefined
[10] Paracelsus Medical University,undefined
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Febrile neutropenia; Cost-effectiveness; Filgrastim; Biosimilar; Pegfilgrastim;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PILOT SURVEY TO ESTIMATE WILLINGNESS TO PAY (WTP) FOR PROPHYLACTIC GRANULOCYTE COLONY-STIMULATING FACTORS (G-CSFS) AMONG PREVIOUSLY TREATED BREAST CANCER PATIENTS
    Johnson, P.
    Bancroft, T. J.
    Barron, R.
    Legg, J.
    Watson, H.
    Naeim, A.
    Watkins, A.
    Marshall, D.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A431 - A432
  • [22] Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy
    Bennett, Charles L.
    Djulbegovic, Benjamin
    Norris, LeAnn B.
    Armitage, James O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (12): : 1131 - 1139
  • [23] Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study
    Tan, Hiangkiat
    Tomic, Karen
    Hurley, Dana
    Daniel, Gregory
    Barron, Rich
    Malin, Jen
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 79 - 86
  • [24] COST-EFFECTIVENESS OF LONG ACTING GRANULOCYTE COLONY STIMULATING FACTOR FOR PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA IN BREAST CANCER IN THE RUSSIA
    Krysanov, I
    Tiapkina, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A734 - A734
  • [25] Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review
    Mitchell, Sarah
    Li, Xiaoyan
    Woods, Matthew
    Garcia, Jacob
    Hebard-Massey, Kerri
    Barron, Rich
    Samuel, Miny
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (05) : 702 - 716
  • [26] Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia
    Freyer, G
    Ligneau, B
    Trillet-Lenoir, V
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1998, 10 (01) : 3 - 9
  • [27] The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs)
    Lambertini, Matteo
    Del Mastro, Lucia
    Bellodi, Andrea
    Pronzato, Paolo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 89 (01) : 112 - 128
  • [28] Use of granulocyte colony stimulating factors (G-CSFs) with multiagent chemotherapy for gestational trophoblastic neoplasia (GTN)
    Kanis, M. J.
    Sobecki-Rausch, J.
    Greendyk, R.
    Dayno, M.
    Lurain, J. R., III
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 218 - 218
  • [29] COST-EFFECTIVENESS ANA LYSIS OF GRANULOCYTE COLONY-STIMULATING FACTORS FOR THE PROPHYLAXIS OF CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA IN GREECE
    Gourzoulidis, G.
    Kourlaba, G.
    Apostolidis, J.
    Lyman, G. H.
    Villa, G.
    Papagiannopoulou, V
    Tritaki, G.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A457 - A457
  • [30] Mechanism of action, efficacy and safety of long-acting granulocyte-colony stimulating factors (G-CSFs) in neutropenia associated with myelotoxic chemotherapy
    Rogowski, Wojciech
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 (02): : 87 - 92
12345